JP2022547524A5 - - Google Patents

Info

Publication number
JP2022547524A5
JP2022547524A5 JP2022515511A JP2022515511A JP2022547524A5 JP 2022547524 A5 JP2022547524 A5 JP 2022547524A5 JP 2022515511 A JP2022515511 A JP 2022515511A JP 2022515511 A JP2022515511 A JP 2022515511A JP 2022547524 A5 JP2022547524 A5 JP 2022547524A5
Authority
JP
Japan
Prior art keywords
sequence
crispr
nucleic acid
related protein
target nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022515511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547524A (ja
JP7705382B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049923 external-priority patent/WO2021050534A1/en
Publication of JP2022547524A publication Critical patent/JP2022547524A/ja
Publication of JP2022547524A5 publication Critical patent/JP2022547524A5/ja
Priority to JP2025109210A priority Critical patent/JP2025161809A/ja
Application granted granted Critical
Publication of JP7705382B2 publication Critical patent/JP7705382B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022515511A 2019-09-09 2020-09-09 新規crispr dnaターゲティング酵素及びシステム Active JP7705382B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025109210A JP2025161809A (ja) 2019-09-09 2025-06-27 新規crispr dnaターゲティング酵素及びシステム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962897859P 2019-09-09 2019-09-09
US62/897,859 2019-09-09
PCT/US2020/049923 WO2021050534A1 (en) 2019-09-09 2020-09-09 Novel crispr dna targeting enzymes and systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025109210A Division JP2025161809A (ja) 2019-09-09 2025-06-27 新規crispr dnaターゲティング酵素及びシステム

Publications (3)

Publication Number Publication Date
JP2022547524A JP2022547524A (ja) 2022-11-14
JP2022547524A5 true JP2022547524A5 (cg-RX-API-DMAC10.html) 2023-09-15
JP7705382B2 JP7705382B2 (ja) 2025-07-09

Family

ID=74866391

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022515511A Active JP7705382B2 (ja) 2019-09-09 2020-09-09 新規crispr dnaターゲティング酵素及びシステム
JP2025109210A Pending JP2025161809A (ja) 2019-09-09 2025-06-27 新規crispr dnaターゲティング酵素及びシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025109210A Pending JP2025161809A (ja) 2019-09-09 2025-06-27 新規crispr dnaターゲティング酵素及びシステム

Country Status (11)

Country Link
US (5) US12460190B2 (cg-RX-API-DMAC10.html)
EP (1) EP4028047A4 (cg-RX-API-DMAC10.html)
JP (2) JP7705382B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220054434A (cg-RX-API-DMAC10.html)
CN (1) CN114340657A (cg-RX-API-DMAC10.html)
AU (1) AU2020347147A1 (cg-RX-API-DMAC10.html)
CA (1) CA3150454A1 (cg-RX-API-DMAC10.html)
IL (1) IL291095A (cg-RX-API-DMAC10.html)
MX (1) MX2022002872A (cg-RX-API-DMAC10.html)
WO (1) WO2021050534A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202202628B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
US12460190B2 (en) * 2019-09-09 2025-11-04 Arbor Biotechnologies, Inc. CRISPR DNA targeting enzymes and systems
WO2021133829A1 (en) 2019-12-23 2021-07-01 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof
CA3211223A1 (en) * 2021-03-09 2022-09-15 Shaorong Chong Compositions comprising a variant polypeptide and uses thereof
CN117043326A (zh) * 2021-03-09 2023-11-10 阿伯生物技术公司 包含变体多肽的组合物及其用途
AU2022234760A1 (en) 2021-03-09 2023-09-14 Arbor Biotechnologies, Inc. Compositions comprising a variant polypeptide and uses thereof
AU2022284804A1 (en) 2021-06-01 2023-12-07 Arbor Biotechnologies, Inc. Gene editing systems comprising a crispr nuclease and uses thereof
WO2023250384A2 (en) * 2022-06-22 2023-12-28 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof
WO2024020557A1 (en) * 2022-07-22 2024-01-25 Arbor Biotechnologies, Inc. Compositions comprising a variant nuclease and uses thereof
US20240035010A1 (en) * 2022-07-22 2024-02-01 Arbor Biotechnologies, Inc. Compositions comprising a variant polypeptide and uses thereof
CN121896200A (zh) * 2022-12-06 2026-04-21 山东舜丰生物科技有限公司 Crispr酶和系统及应用
US20260232844A1 (en) 2023-02-15 2026-08-13 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2025006563A1 (en) 2023-06-26 2025-01-02 Arbor Biotechnologies, Inc. Gene editing systems targeting pcsk9 and uses thereof
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025212120A1 (en) 2024-04-05 2025-10-09 Arbor Biotechnologies, Inc. Chemical modifications of guide rnas for crispr nucleases
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026139426A1 (en) * 2024-12-26 2026-07-02 UCB Biopharma SRL Novel rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US20040052799A1 (en) 1996-11-15 2004-03-18 Astra Aktiebolag Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
US20040216190A1 (en) * 2003-04-28 2004-10-28 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
EP2397490B1 (en) 2004-07-16 2013-09-04 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV
US8703147B2 (en) * 2007-11-05 2014-04-22 The Walter And Eliza Hall Institute Of Medical Research Methods and compositions for treating and preventing malaria (2)
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
WO2013082500A2 (en) 2011-12-02 2013-06-06 Rhode Island Hospital Vaccine for falciparum malaria
KR102955556B1 (ko) 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
WO2016094874A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Escorted and functionalized guides for crispr-cas systems
EP3230452B1 (en) 2014-12-12 2025-06-11 The Broad Institute, Inc. Dead guides for crispr transcription factors
US20180187190A1 (en) * 2015-06-12 2018-07-05 Erasmus University Medical Center Rotterdam New crispr assays
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
CA3012631A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
CN116814590A (zh) * 2015-10-22 2023-09-29 布罗德研究所有限公司 Vi-b型crispr酶和系统
CA3026110A1 (en) 2016-04-19 2017-11-02 The Broad Institute, Inc. Novel crispr enzymes and systems
US10125246B2 (en) * 2016-06-24 2018-11-13 King Fahd University Of Petroleum And Minerals Low density polyethylene (LDPE)-asphaltene composition and method of preparation
EP3526326A4 (en) 2016-10-12 2020-07-29 The Regents of The University of Colorado, A Body Corporate NEW MODIFIED AND CHEMERICAL NUCLEASES
US10392616B2 (en) 2017-06-30 2019-08-27 Arbor Biotechnologies, Inc. CRISPR RNA targeting enzymes and systems and uses thereof
US12460190B2 (en) 2019-09-09 2025-11-04 Arbor Biotechnologies, Inc. CRISPR DNA targeting enzymes and systems

Similar Documents

Publication Publication Date Title
JP2022546701A5 (cg-RX-API-DMAC10.html)
JP2025161809A5 (cg-RX-API-DMAC10.html)
JP2022546594A5 (cg-RX-API-DMAC10.html)
US10988781B2 (en) Method of target cleaving using CRISPR hybrid DNA/RNA polynucleotides
JP2022540153A5 (cg-RX-API-DMAC10.html)
EP3325018B1 (en) High-throughput screening of regulatory element function with epigenome editing technologies
JP2021521788A (ja) ゲノム編集のための組成物および方法
JP2022538789A5 (cg-RX-API-DMAC10.html)
US20200172935A1 (en) Modified cpf1 mrna, modified guide rna, and uses thereof
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
FI3765615T3 (fi) Uusia DNA:han kohdentuvia CRISPR-entsyymejä ja järjestelmiä
Hess et al. Sequence and structure determinants of Drosophila Hsp70 mRNA translation: 5′-UTR secondary structure specifically inhibits heat shock protein mRNA translation
US12275951B2 (en) Engineered guide RNA and uses thereof
JP2024524514A5 (cg-RX-API-DMAC10.html)
CN110343724B (zh) 用于筛选和鉴定功能性lncRNA的方法
CN112384620B (zh) 用于筛选和鉴定功能性lncRNA的方法
US12534752B2 (en) Methods and compositions for selective cleavage of nucleic acids with recombinant nucleases
WO2019206233A1 (zh) 一种RNA编辑的CRISPR/Cas效应蛋白及系统
EP3929292A1 (en) System and method for genome editing based on c2c1 nucleases
JP2024531607A5 (cg-RX-API-DMAC10.html)
Krinner et al. Interplay of promoter usage and intragenic CpG content: impact on GFP reporter gene expression
US20250277256A1 (en) Nucleic acid detection and analysis systems
CN116355877A (zh) Cas13蛋白、CRISPR-Cas系统及其应用
CN113652411A (zh) Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用
WO2020077110A1 (en) Compositions and methods for modifying regulatory t cells